A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF)

Collapse authors list.
Heidarali, Mona, Bakhshandeh, Hooman, Golpira, Reza, Fazelifar, Amirfarjam, Alizadeh-Diz, Abolfath, Emkanjoo, Zahra, Madadi, Shabnam, Kamali, Farzad, Maleki, Majid, Lip, Gregory YH ORCID: 0000-0002-7566-1626 et al (show 1 more authors) and Haghjoo, Majid (2021) A prospective survey of atrial fibrillation management in Iran: Baseline results of the Iranian Registry of Atrial Fibrillation (IRAF). INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 75 (8). e14313-.

Text
IRAF paper 181020.doc - Author Accepted Manuscript
Download (220kB)

Official URL: http://dx.doi.org/10.1111/ijcp.14313

Abstract

<h4>Background</h4>Atrial fibrillation. (AF) is the most common sustained arrhythmia globally and its prevalence is likely to increase in the next decades as a result of increasing age and co-morbidities. There are no data on demographic features, clinical characteristics, associated comorbidities, and practice patterns of AF in Iran.<h4>Methods</h4>The Iranian Registry of Atrial Fibrillation (IRAF) is a hospital-based prospective survey of AF patients with a 12-month follow-up. Data were collected on a standardized case report form and entered into a web-based electronic database. This paper reports the baseline characteristics of the IRAF cohort.<h4>Results</h4>Between February 2018 and March 2020, a total of 1300 patients (57% Male, mean age, 60 ± 14 years) were enrolled. Palpitations were the most common presenting symptom (66%). The most common cardiac comorbidities were hypertension (52%), heart failure (23.7%), and valvular heart disease (21.8%). AF mainly presented as a paroxysmal pattern (44.6%). Seventy-eight percent of the patients with non-valvular AF had CHA<sub>2</sub> DS<sub>2</sub> -VASc score ≥1 and most (97%) were at low risk for bleeding (HAS-BLED score <3). Rhythm control was given to 55.1% of the patients. Anticoagulation for stroke prevention was provided to 69.5% of the eligible patients, while aspirin was used in 35%.<h4>Conclusion</h4>The IRAF Registry has provided a systematic collection of contemporary data regarding the management and treatment of AF in Iran. Oral anticoagulant was used in 69.5%, but aspirin use was still common.

Item Type:	Article
Uncontrolled Keywords:	Humans, Atrial Fibrillation, Anticoagulants, Registries, Risk Factors, Prospective Studies, Aged, Middle Aged, Iran, Female, Male, Stroke
Divisions:	Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User:	Symplectic Admin
Date Deposited:	21 Jun 2021 09:25
Last Modified:	25 Sep 2023 13:15
DOI:	10.1111/ijcp.14313
Related URLs:	Author Publisher
URI:	https://livrepository.liverpool.ac.uk/id/eprint/3127156